Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease

Pediatric Research

Volumn 49, Issue 5, 2001, Pages 686-690

  Quasney, M W ^a   Bronstein, D E ^a   Cantor, R M ^a   Zhang, Q ^a   Stroupe, C ^a   Shike, H ^a   Bastian, J F ^a   Matsubara, T ^a   Fujiwara, M ^a   Akimoto, K ^a   Newburger, J W ^a   Burns, J C ^a  

^a LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; IMMUNOGLOBULIN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0035028448     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200105000-00013     Document Type: Article

References (42)

1. Nationwide survey of Kawasaki disease and acute rheumatic fever
2. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan
3. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan
4. Mucocutaneous lymph node syndrome in the United States
5. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome
6. National surveillance of Kawasaki disease
7. HLA antigens in Kawasaki disease
8. HLA antigens in mucocutaneous lymph node syndrome
9. HLA antigens in mucocutaneous lymph node syndrome in New England
10. Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome in New England
11. HLA-Bw51 is increased in mucocutaneous lymph node syndrome in israel patients
12. The HLA class II region and susceptibility to Kawasaki disease
13. Immunoglobulin allotypic markers in Kawasaki disease
14. Immunologic aspects of Kawasaki disease: Implications for pathogenesis and therapy
15. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)
16. The changes of interleukin-2 tumor necrosis factor and gamma-interferon production among patients with Kawasaki disease
17. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease
18. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions
19. Spontaneous tumor necrosis factor production in Kawasaki disease
20. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon
21. Two monokines, interleukin-1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki disease
22. Human lymphotoxin and tumor necrosis factor genes: Structure, homology and chromosomal localization
23. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
24. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese
25. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor concentrations and outcome of patients with severe sepsis
26. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNT promoter
27. Association of tumor necrosis factor (TNT) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus
28. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease
29. Single base polymorphism in the human tumor necrosis factor alpha (TNF) gene detectable by Ncol restriction of PCR product
30. Nco I restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFα) region in primary biliary cirrhosis and in healthy Danes
31. 10.5-kb homozygote of tumor necrosis factor-beta gene is associated with a better prognosis in gastric cancer patients
32. Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3′-untranslated region of tumor necrosis factor-alpha
33. Binding of a protein to an AU-rich domain of tumor necrosis factor alpha mRNA as a 35kDa complex and its regulation in primary rat astrocytes
34. Increased monocyte TNF-α message stability contributes to trauma patients' increased TNF production
35. Post-transcriptional regulation of UV induced TNT-α expression
36. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease
37. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease
38. Tumor necrosis factor and disease severity in children with falciparum malaria
39. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
40. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
41. The -308 tumor necrosis factor-α promoter polymorphism effects transcription